MX2025011286A - Formulaciones vacunales basadas en proteinas meningococicas y metodos para su fabricacion - Google Patents

Formulaciones vacunales basadas en proteinas meningococicas y metodos para su fabricacion

Info

Publication number
MX2025011286A
MX2025011286A MX2025011286A MX2025011286A MX2025011286A MX 2025011286 A MX2025011286 A MX 2025011286A MX 2025011286 A MX2025011286 A MX 2025011286A MX 2025011286 A MX2025011286 A MX 2025011286A MX 2025011286 A MX2025011286 A MX 2025011286A
Authority
MX
Mexico
Prior art keywords
manufacturing
methods
fusion proteins
vaccine formulations
protein based
Prior art date
Application number
MX2025011286A
Other languages
English (en)
Spanish (es)
Inventor
Sambhaji Shankar Pisal
Dattatreya Sarma Annamraju
Rajeev Mhalasakant Dhere
Original Assignee
Serum Institute Of India Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serum Institute Of India Pvt Ltd filed Critical Serum Institute Of India Pvt Ltd
Publication of MX2025011286A publication Critical patent/MX2025011286A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
MX2025011286A 2023-03-24 2025-09-24 Formulaciones vacunales basadas en proteinas meningococicas y metodos para su fabricacion MX2025011286A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN202321021121A IN202321021121A (enExample) 2023-03-24 2023-03-24
PCT/IN2024/050300 WO2024201502A1 (en) 2023-03-24 2024-03-22 Meningococcal protein based vaccine formulations and methods for manufacturing thereof

Publications (1)

Publication Number Publication Date
MX2025011286A true MX2025011286A (es) 2025-11-03

Family

ID=92903953

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2025011286A MX2025011286A (es) 2023-03-24 2025-09-24 Formulaciones vacunales basadas en proteinas meningococicas y metodos para su fabricacion

Country Status (9)

Country Link
KR (1) KR20250166279A (enExample)
CN (1) CN121038809A (enExample)
AR (1) AR132199A1 (enExample)
AU (1) AU2024249503A1 (enExample)
IL (1) IL323559A (enExample)
IN (1) IN202321021121A (enExample)
MX (1) MX2025011286A (enExample)
TW (1) TW202444740A (enExample)
WO (1) WO2024201502A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119925588B (zh) * 2025-04-08 2025-07-01 北京华诺泰生物医药科技有限公司 基于gE/pORF7双抗原纳米晶与智能相变佐剂的重组带状疱疹疫苗
CN120227449A (zh) * 2025-05-21 2025-07-01 苏州聚微生物科技有限公司 B群脑膜炎球菌疫苗组合物及其制备方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3017828A1 (en) * 2009-08-27 2016-05-11 GlaxoSmithKline Biologicals SA Hybrid polypeptides including meningococcal fhbp sequences
BR112015022292A2 (pt) * 2013-03-15 2017-07-18 Childrens Hospital Philadelphia processo de fabricação escalonável para produzir vetores lentivirais recombinantes em um sistema de cultura celular em suspensão sem soro
GB201614687D0 (en) * 2016-08-31 2016-10-12 Univ Oxford Innovation Ltd fHbp scaffold
CN110804102B (zh) * 2019-11-08 2021-07-20 苏州微超生物科技有限公司 B群脑膜炎球菌疫苗及其制备方法与应用

Also Published As

Publication number Publication date
IN202321021121A (enExample) 2024-04-19
IL323559A (en) 2025-11-01
KR20250166279A (ko) 2025-11-27
CN121038809A (zh) 2025-11-28
AR132199A1 (es) 2025-06-04
WO2024201502A1 (en) 2024-10-03
TW202444740A (zh) 2024-11-16
AU2024249503A1 (en) 2025-10-16

Similar Documents

Publication Publication Date Title
MX2025011286A (es) Formulaciones vacunales basadas en proteinas meningococicas y metodos para su fabricacion
WO2007024941A3 (en) Polyvalent vaccine
MX2007003402A (es) Composicion inmunogena para su uso en vacunacion contra estafilococos.
MX2022015040A (es) Proteina espicular (s) del coronavirus geneticamente manipulada y metodos de uso de la misma.
WO2021154812A8 (en) Coronavirus vaccine formulations
WO2021216743A3 (en) Coronavirus vaccines, compositions, and methods related thereto
ATE421533T1 (de) Immunogene t-helfer epitope von menschlichen tumorantigenen und deren verwendung in immunotherapeutischen methoden
WO2010019262A3 (en) Polyvalent vaccine
WO2007092792A3 (en) Yeast-based vaccine for inducing an immune response
PL1635863T3 (pl) Kompozycje do wywoływania, wzmacniania i utrzymywania odpowiedzi immunologicznych na epitopy ograniczone do MHC klasy I do celów profilaktycznych i leczniczych
TW200507874A (en) Immunostimulatory nucleic acid oil-in-water formulations and related methods of use
IL138075A0 (en) Vaccines, immunotherapeutics and methods for using the same
PT1897555E (pt) Vacina omv suplementada contra meningococos
WO2006046978A3 (en) Cationic peptide-mediated transformation
PL2054431T3 (pl) Konformery adhezyn bakteryjnych
WO2008034074A3 (en) Cyclosphosphamide in combination with anti-idiotypic vaccines
WO2023102448A3 (en) Coronavirus vaccine formulations
WO2019241672A3 (en) Glycosylated comp pilin variants, methods of making and uses thereof
WO2010120874A3 (en) Chimeric therapeutics, compositions, and methods for using same
WO2008118487A3 (en) Compositions and methods for incresing immunogenicity of glycoprotein vaccines
AU2002319501A1 (en) Materials and methods relating to improved vaccination strategies
WO2002034287A3 (en) Therapeutic vaccine formulations containing chitosan
WO2021247715A3 (en) Immunogenic francisella antigens and their use in immunization of fish against francisellosis
AU2003255275A1 (en) Improved anthrax vaccines and delivery methods
MX2023009728A (es) Vacuna recombinante meningococica b.